BCBS TexasMedium ImpactCoverage
Member Benefit Coverage for Viscosupplementation for Osteoarthritis will End Jan. 1, 2026
Published January 12, 2026Effective January 1, 2026
AI Summary
Blue Cross Blue Shield of Texas will discontinue coverage for viscosupplementation injections for osteoarthritis treatment effective January 1, 2026. Some members currently receiving maintenance injections may continue coverage through 2026 and will be notified directly.
Action Required
Before January 1, 2026: Billing team must update systems to flag viscosupplementation procedures for osteoarthritis as non-covered for BCBSTX commercial members. Verify eligibility and benefits through Availity Essentials before rendering services. For patients currently on maintenance therapy, confirm individual coverage continuation through member notifications.
Plan Types
Commercial
States
TX
Specialties
ortho, rheumatology, family-medicine, internal-medicine, pain-management